Similar articles

• Renin inhibition: what are the clinical perspectives?

  Hollenberg NK. Hollenberg NK. Semin Nephrol. 2007 Sep;27(5):511-8. doi: 10.1016/j.semnephrol.2007.07.006. Semin Nephrol. 2007. PMID: 17868787 Review.
• Angiotensin receptor blockers: novel role in high-risk patients.

  Javed U, Deedwania PC. Javed U, et al. Cardiol Clin. 2008 Nov;26(4):507-26. doi: 10.1016/j.ccl.2008.07.001. Cardiol Clin. 2008. PMID: 18929228 Review.
• Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?

  Ram CV, Deedwania PC. Ram CV, et al. Am J Cardiol. 2008 Nov 1;102(9):1281-3. doi: 10.1016/j.amjcard.2008.06.043. Epub 2008 Aug 15. Am J Cardiol. 2008. PMID: 18940307 No abstract available.
• Hypertension. Update on use of angiotensin II receptor blockers.

  Jacobson EJ. Jacobson EJ. Geriatrics. 2001 Feb;56(2):20-1, 25-8. Geriatrics. 2001. PMID: 11219021 Review.
• A vaccine for hypertension.

  Ménard J. Ménard J. J Hypertens. 2007 Jan;25(1):41-6. doi: 10.1097/HJH.0b013e328012981b. J Hypertens. 2007. PMID: 17143170 No abstract available.